Security
Medicus Pharma Ltd. Common Stock · MDCX
MDCXNASDAQCommon stockCurrentCIK 1997296Updated Nov 10, 2026
MDCX price & chart
Loading TradingView…
NASDAQ:MDCX on TradingView ↗About the company
We are a clinical-stage, multi-strategy, life science and biotech company focused on investing in and accelerating the clinical development programs of novel and disruptive therapeutic assets. Currently, we are developing two products, SkinJectTM ("SkinJectTM"), with an indication for basal cell carcinoma, and Teverelix trifluoroacetate ("Teverelix", and together with SkinJectTM, the "Products").
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| AssetsUSD | 9,977,661Source | 27,116,185Source | 11,934,628Source | 7,426,911Source | 5,657,866Source | 10,061,377Source | 5,646,878Source | 1,893,057Source |
| Current assets: | ||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 8,662,091Source | 15,174,128Source | 9,669,546Source | 6,365,624Source | 3,982,430Source | 8,705,218Source | 4,164,323Source | 1,719,338Source |
| Assets, CurrentUSD | 9,781,412Source | 16,981,589Source | 10,996,731Source | 7,282,580Source | 5,087,775Source | 9,890,644Source | 5,378,307Source | 1,893,057Source |
| Operating Lease, Right-of-Use AssetUSD | 196,249Source | 117,184Source | 220,999Source | 144,331Source | 245,091Source | 170,733Source | 268,571Source | 0Source |
| LIABILITIES AND EQUITY | ||||||||
| LiabilitiesUSD | 10,782,551Source | 28,841,149Source | 8,685,918Source | 5,999,017Source | 3,510,312Source | 10,024,066Source | 2,512,174Source | 781,609Source |
| Stockholders’ equity: | ||||||||
| Common Stock, Value, IssuedUSD | 4Source | 74,298,513Source | 37,833,999Source | 67,114,012Source | 32,908,702Source | 57,076,175Source | 30,518,195Source | 18,761,250Source |
| Additional Paid in CapitalUSD | 6,449,863Source | 8,884,707Source | 5,597,106Source | 7,478,881Source | 3,245,163Source | 6,879,575Source | 1,520,412Source | 98,585Source |
| Retained Earnings (Accumulated Deficit)USD | -5Source | -85,007,966Source | -40,182,395Source | -73,390,261Source | -34,006,311Source | -64,348,118Source | -28,903,903Source | -17,748,387Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 10,676Source | 61,095Source | — | -190,510Source | — | 10,880Source | — | — |
| Stockholders' Equity Attributable to ParentUSD | -910,126Source | -1,763,651Source | — | 1,326,056Source | — | -67,554Source | — | — |
| Liabilities and EquityUSD | 9,977,661Source | 27,116,185Source | 11,934,628Source | 7,426,911Source | 5,657,866Source | 10,061,377Source | 5,646,878Source | 1,893,057Source |
| Current liabilities: | ||||||||
| Liabilities, CurrentUSD | 10,657,901Source | 10,841,493Source | 8,544,165Source | 5,953,807Source | 3,335,915Source | 9,938,062Source | 2,306,229Source | 781,609Source |
| Operating Lease, Liability, CurrentUSD | 141,070Source | 137,330Source | 124,402Source | 145,456Source | 120,296Source | 145,456Source | 116,323Source | 0Source |
| Accounts Payable, CurrentUSD | 2,027,509Source | 6,734,310Source | 1,770,178Source | 2,278,619Source | 2,035,364Source | 3,435,297Source | 1,284,612Source | 210,842Source |
| Operating Lease, Liability, NoncurrentUSD | 95,188Source | 0Source | 141,753Source | 24,168Source | 174,397Source | 60,139Source | 205,945Source | 0Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 105,236Source | 38,687Source | — | 101,838Source | — | 104,865Source | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -15,981,312Source | -2,278,747Source | -11,684,427Source | -6,176,084Source | -9,042,311Source | -5,102,408Source | -35,444,361Source | -11,155,516Source | -5,314,765Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 599,306Source | 112,277Source | 1,512,194Source | 713,119Source | 98,585Source |
| Changes in operating assets and liabilities: | |||||||||||
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | — | 655,634Source | — | 808,745Source | 79,088Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -8,969,688Source | -3,940,994Source | -22,776,769Source | -10,247,231Source | -4,158,264Source |
| Cash flows from investing activities: | |||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | — | -4,619,152Source | — | — |
| Cash flows from financing activities: | |||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 6,825,151Source | 3,759,101Source | 31,939,785Source | 12,692,216Source | 5,609,950Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -2,339,594Source | -181,893Source | 4,540,895Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 8,662,091Source | 5,306,159Source | 25,191,540Source | 9,669,546Source | 6,365,624Source | 3,982,430Source | 8,705,218Source | 4,164,323Source | 1,719,338Source |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 96,393Source | 0Source | 221,663Source | 40,563Source | 0Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -195,057Source | 0Source | -2,969Source | — | — |
| Additional Financial Items | |||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 852,757Source | 0Source | 1,405,826Source | 117,448Source | 599,306Source | 112,277Source | 1,512,194Source | 713,119Source | 98,585Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | 10,828Source | 0Source | — | — | -204,249Source | 0Source | -10,730Source | — | — |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | — | — | — | — | — | — | -41,947Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | -25,000Source | 0Source | — | — | — | — | -25,000Source | — | — |
| General and Administrative ExpenseUSD | — | — | 5Source | 1,770,116Source | 6,571,097Source | 4,576,524Source | 5,892,684Source | 3,120,060Source | 17,920,391Source | 7,653,116Source | 4,536,367Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -20,935,753Source | -2,278,747Source | -11,617,705Source | -6,176,084Source | -9,042,143Source | -5,102,408Source | -47,281,513Source | -11,155,516Source | -5,314,765Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -77Source | 0Source | -66,722Source | 0Source | -168Source | 0Source | -146Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -2,278,747Source | — | -6,176,084Source | -9,042,311Source | -5,102,408Source | -47,281,659Source | -11,155,516Source | -5,314,765Source |
| Operating ExpensesUSD | — | — | 15Source | 2,334,261Source | 11,478,789Source | 6,016,088Source | 8,597,077Source | 5,126,274Source | 34,359,302Source | 11,180,902Source | 4,729,945Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | 30,944Source | 30,945Source | 123,777Source | 123,777Source | — |
| Other Nonoperating Income (Expense)USD | — | — | -554,972Source | 55,514Source | -205,638Source | -159,996Source | -445,234Source | 23,866Source | -1,085,059Source | 25,386Source | -584,820Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 0Source | 3,784,101Source | 9,790,015Source | 5,470,000Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | 162,400Source | — | — |
| Payments of Financing Costs | — | — | — | — | — | — | —Source | —Source | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | -15Source | -2,334,261Source | -11,478,789Source | -6,016,088Source | -8,597,077Source | -5,126,274Source | -34,359,302Source | -11,180,902Source | -4,729,945Source |
| Other Nonoperating Income (Expense)USD | — | — | -554,972Source | 55,514Source | -205,638Source | -159,996Source | -445,234Source | 23,866Source | -1,085,059Source | 25,386Source | -584,820Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -77Source | 0Source | -66,722Source | 0Source | -168Source | 0Source | -146Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -20,935,753Source | -2,278,747Source | -11,617,705Source | -6,176,084Source | -9,042,143Source | -5,102,408Source | -47,281,513Source | -11,155,516Source | -5,314,765Source |
| Earnings Per Share, BasicUSD per share | — | — | -1.12Source | -0.24Source | -0.21Source | -0.43Source | -0.31Source | -0.42Source | -2.74Source | -1.16Source | -1.53Source |
| Earnings Per Share, DilutedUSD per share | — | — | -1.12Source | -0.24Source | -0.21Source | -0.43Source | -0.31Source | -0.42Source | -2.74Source | -1.16Source | -1.53Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 18,631,668Source | 9,514,738Source | 55,055,225Source | 14,284,261Source | 29,540,833Source | 12,240,437Source | 17,283,824Source | 9,619,184Source | 3,479,494Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 18,631,668Source | 9,514,738Source | 55,055,225Source | 14,284,261Source | 29,540,833Source | 12,240,437Source | 17,283,824Source | 9,619,184Source | 3,479,494Source |
| Additional Financial Items | |||||||||||
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | 10,828Source | 0Source | — | — | -204,249Source | 0Source | -10,730Source | — | — |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | — | — | — | — | — | — | -41,947Source | — | — |
| General and Administrative ExpenseUSD | — | — | 5Source | 1,770,116Source | 6,571,097Source | 4,576,524Source | 5,892,684Source | 3,120,060Source | 17,920,391Source | 7,653,116Source | 4,536,367Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -16,817,273Source | -6,187,172Source | -3,290,979Source |
| Interest Income (Expense), NetUSD | — | — | 11,572Source | 55,514Source | — | 40,004Source | — | — | -197,382Source | — | — |
| Investment Income, NetUSD | — | — | — | — | 0Source | 40,004Source | 56,561Source | 23,866Source | — | 25,386Source | -584,820Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -2,278,747Source | — | -6,176,084Source | -9,042,311Source | -5,102,408Source | -47,281,659Source | -11,155,516Source | -5,314,765Source |
| Operating ExpensesUSD | — | — | 15Source | 2,334,261Source | 11,478,789Source | 6,016,088Source | 8,597,077Source | 5,126,274Source | 34,359,302Source | 11,180,902Source | 4,729,945Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | 30,944Source | 30,945Source | 123,777Source | 123,777Source | — |
| Research and Development ExpenseUSD | — | — | 1,684,783Source | 564,145Source | 4,907,692Source | 1,439,564Source | 2,704,393Source | 2,006,214Source | 7,721,436Source | 3,527,786Source | 193,578Source |
| Interest Expense | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — |
| Labor and Related Expense | — | — | — | — | —Source | —Source | — | — | — | — | — |
Offerings
Registration 333-290585
Registration 333-290586
Registration 333-293091
Registration 333-291651
Registration 333-287599
- Gross proceeds
- 7006000.0
- Net proceeds
- 6480550.0
- Deal price
- 3.1
- Shares
- 2260000
- Offering price
- $3.1000